You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國邦醫藥(605507.SH):全資子公司頭孢丙烯原料藥獲得CEP證書
格隆匯 11-05 16:33

格隆匯11月5日丨國邦醫藥(605507.SH)公佈,近日,公司全資子公司東盈藥業收到了歐洲藥品質量管理局簽發的頭孢丙烯原料藥CEP證書。截止公吿日,該原料藥還進行了韓國MFDS註冊,獲得了批准。

本次頭孢丙烯原料藥獲得CEP證書,顯示歐洲規範市場對公司該原料藥質量的認可和肯定,標誌着該原料藥產品可以在歐洲市場進行銷售,截至公吿日,公司已有阿奇黴素、克拉黴素、鹽酸環丙沙星、恩諾沙星等共9個品種獲得CEP證書,為公司進一步拓展國際市場帶來積極的影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account